Uni-Bio Science Group Limited

HK$0.06As of Sun 8 Nov 2026, 12:00 UTC
HKEX:0690Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (8.37%)
Div yield 4.89%
ROE 11.67%
Biotechnology
Beta (5Y) (0.10)
PE TTM 7.902
TSR TTM (47.79%)
Mkt cap HK$382.2M
ROIC 12.61%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0829
29.51%
95.44%
Buy 11|0|12|9|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
37.10%
24.57%
18.66%
9.53%
Revenue$M
24.11
24.88
24.19
23.80
0.56%
6.25%
2.86%
0.29%
Peers (US$48.75M)
Cap (US$)
PE
59.29M
—
31.89M
—
Capital
TTM
5Y
10Y
Leveragex
1.218
—
—
EBIT/Intx
2.241
0.212
0.207
Own earn%
(26.28)
(83.26)
(76.07)
Sh yield%
40.05
1.46
5.81
Owners
Insiders/Inst%
8.35
85.24
Short interest%
2.85
SBC / revenue%
5.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
2–4
$1 testx
—
Incr. ROIC%
1